CA1124677A - Radiation treated propylene polymers - Google Patents
Radiation treated propylene polymersInfo
- Publication number
- CA1124677A CA1124677A CA345,495A CA345495A CA1124677A CA 1124677 A CA1124677 A CA 1124677A CA 345495 A CA345495 A CA 345495A CA 1124677 A CA1124677 A CA 1124677A
- Authority
- CA
- Canada
- Prior art keywords
- article
- independently
- group
- ppm
- propylene polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/16—Nitrogen-containing compounds
- C08K5/34—Heterocyclic compounds having nitrogen in the ring
- C08K5/3467—Heterocyclic compounds having nitrogen in the ring having more than two nitrogen atoms in the ring
- C08K5/3477—Six-membered rings
Abstract
HIGH ENERGY RADIATION TREATED STABILIZED PROPYLENE POLYMERS
ABSTRACT
A propylene polymer molding composition which is resis-tant to high energy radiation induced discoloration and losses of physical properties is obtained by incorporation of a phenolic isocyanurate compound as a stabilizer, in conjunction with a thio-synergist, and preferably a stearate.
ABSTRACT
A propylene polymer molding composition which is resis-tant to high energy radiation induced discoloration and losses of physical properties is obtained by incorporation of a phenolic isocyanurate compound as a stabilizer, in conjunction with a thio-synergist, and preferably a stearate.
Description
~:
.
.
. BACKGROUND OF THE INVENTION
This invention relates to compositions of propylene polymers suitable for high energy radiation treatment. One aspect .5 of the invention relates to propylene polymer compositions of specific characteristics which have been subjected to sterilizing dosages of high energy radiation, such as gamma radiation.
Propylene polymers, and specifically those of a substan-tial crystalline content have been applied to many new uses, which O ~ uses have required that the polymer be processed or treated in a particular manner. For example, propylene polymers generally have the contact clarity, heat distortion resistance arld low chemical ?~ reactivity required by manufacturers of medical single-use items such as syringes, forceps, surgical clamps and various instrument trays, etc., used in the operating room. Obviously, before any such articles can be safely used, it is required that it be steri-lized.
Ethylene oxide has the sterilizing effectiveness needed by these same manufacturers, and until recently was regarded as ,g - 1 - ~k ~! generally safe. Recently, however, ethylene oxide has come under ¦increasing scrutiny by the authorities, since it is believed to be a mutagen and possibly a carcinogen. Acceptable limits of resid-ual ethylene oxide and its by-products have therefore been lowered.
In addition, the cost of ethylene oxide is rising, and the steril-~
izing costs (because of a 14-day holding requirement and the indi-vidual batch testing requirement) are becoming non-competitive.
High energy radiation, on the other hand, leaves no res-idue and has a dose-related sterilization rate which permits immediate release upon certification of the dose. However, unlike ethylene oxide, radiation, especially r -radiation, damages the polymer, in that it causes either embrittlement or discoloration or both of these effects occur simultaneously: As disclosed in U.S. Patent No. 3,537,967 and in its Canadian counterpart Canadian Patent No. 811,766, the discoloration is attributable to the use of phenolic antioxidants in the compositions to prevent or minimiz the radiation induced degradation of the polymer. Even worse dis-coloration is obtained with additive systems containing a phenolic antioxidant and a thiodipropionic ester synergist. The patents teach that discoloration resistance upon high energy radiation is achieved by the incorporation into the polymer of the ester of thiodipropionic ester as the sole stabilizer. However, these com-positions have been found not to be entirely satisfactory espe-cially for use in the fabrication of syringes, in that the strengt~
retention (flexural strength) of the irradiated polymer is minimal even at high levels of thiodipropionic ester incorporation, and the sterilized article becomes so embrittled, that it is prone to breakage in use. Also, because of the known lesser efficiency of thiosynergists in providing long term stability a~ainst oxidative ¦degradation of propylene polymers as compared to that of phenolic ¦antioxidants, the shelf life of articles manufactured from the compositions of U.S. Patent No. 3,537,967 and Canadian Patent No.
811,766 is not as long as would be desired.
~lirao in U.S. Patent No. 3,940,325 teaches that the dis-advantages of the compositions of the aforementione~ patents can
.
.
. BACKGROUND OF THE INVENTION
This invention relates to compositions of propylene polymers suitable for high energy radiation treatment. One aspect .5 of the invention relates to propylene polymer compositions of specific characteristics which have been subjected to sterilizing dosages of high energy radiation, such as gamma radiation.
Propylene polymers, and specifically those of a substan-tial crystalline content have been applied to many new uses, which O ~ uses have required that the polymer be processed or treated in a particular manner. For example, propylene polymers generally have the contact clarity, heat distortion resistance arld low chemical ?~ reactivity required by manufacturers of medical single-use items such as syringes, forceps, surgical clamps and various instrument trays, etc., used in the operating room. Obviously, before any such articles can be safely used, it is required that it be steri-lized.
Ethylene oxide has the sterilizing effectiveness needed by these same manufacturers, and until recently was regarded as ,g - 1 - ~k ~! generally safe. Recently, however, ethylene oxide has come under ¦increasing scrutiny by the authorities, since it is believed to be a mutagen and possibly a carcinogen. Acceptable limits of resid-ual ethylene oxide and its by-products have therefore been lowered.
In addition, the cost of ethylene oxide is rising, and the steril-~
izing costs (because of a 14-day holding requirement and the indi-vidual batch testing requirement) are becoming non-competitive.
High energy radiation, on the other hand, leaves no res-idue and has a dose-related sterilization rate which permits immediate release upon certification of the dose. However, unlike ethylene oxide, radiation, especially r -radiation, damages the polymer, in that it causes either embrittlement or discoloration or both of these effects occur simultaneously: As disclosed in U.S. Patent No. 3,537,967 and in its Canadian counterpart Canadian Patent No. 811,766, the discoloration is attributable to the use of phenolic antioxidants in the compositions to prevent or minimiz the radiation induced degradation of the polymer. Even worse dis-coloration is obtained with additive systems containing a phenolic antioxidant and a thiodipropionic ester synergist. The patents teach that discoloration resistance upon high energy radiation is achieved by the incorporation into the polymer of the ester of thiodipropionic ester as the sole stabilizer. However, these com-positions have been found not to be entirely satisfactory espe-cially for use in the fabrication of syringes, in that the strengt~
retention (flexural strength) of the irradiated polymer is minimal even at high levels of thiodipropionic ester incorporation, and the sterilized article becomes so embrittled, that it is prone to breakage in use. Also, because of the known lesser efficiency of thiosynergists in providing long term stability a~ainst oxidative ¦degradation of propylene polymers as compared to that of phenolic ¦antioxidants, the shelf life of articles manufactured from the compositions of U.S. Patent No. 3,537,967 and Canadian Patent No.
811,766 is not as long as would be desired.
~lirao in U.S. Patent No. 3,940,325 teaches that the dis-advantages of the compositions of the aforementione~ patents can
2~77 .1 ~lbe overcome provided that as phenolic antioxidant an addi~ive jselected only from either octadecyl 3,5-dl-t-butyl-4-hydroxyhydro-¦,cinnamate or/and tetrakis[methylene(3l5-di-~-butyl-4-hydroxyhydro-¦¦cinnamate)] methane be used. Many other propylene polymers con-l¦tainin~ combinations of various antioxidant thiosynergist and lu-¦bricant additives were tested by Hirao at various concentration levels and were found to be deficient, including those containing phenolic isocyanurate stabilizers.
According to Gilles in U.S. Patent No. 3,644,277, such isocyanurate compounds provide stability against oxidative, therma and photochemical degradation, but nothing is said regarding the effectiveness of the additives during high energy radiation.
Gilles also teaches that synergistic activity is obtained when his specific isocyanurates are combined with thiosynergists such as the well known diesters of ~ -thiodipropionic acid of the afore-¦mentioned U.S. Patent No. 3,537 r 967. In order to achieve this beneficial synergistic effect the weigh~ ratio of thiosynergist to l isocyanurate stabilizers should be between about 1:1 and up to ! about 5:1. This ratio range is typical for most other antioxidant ~0 ¦ thiosynergist combinations, e.g. those shown and discussed by ¦IHirao in U.S. Patent No. 3,940j325.
It is an object of the present invention to provide l¦novèl compositions of matter of polymers of propylene which are ;Iresistant to discoloration and to degradation of physical proper-¦¦ties upon high energy radiation treatment.
It is a further object of this invention to provide ¦¦shaped articles of polymers of propylene which can be used for medical or food packaging purposes, which shaped articles have ~been subjected to a sterilizing dose of high energy radiation.
¦I THE INVENTION
¦ The above objects are unexpectedly accomplished by in-corporating into a propylene polymer (a) from about 200 to about 400 ppm of a phenolic antioxidant containing an isocyanurate group
According to Gilles in U.S. Patent No. 3,644,277, such isocyanurate compounds provide stability against oxidative, therma and photochemical degradation, but nothing is said regarding the effectiveness of the additives during high energy radiation.
Gilles also teaches that synergistic activity is obtained when his specific isocyanurates are combined with thiosynergists such as the well known diesters of ~ -thiodipropionic acid of the afore-¦mentioned U.S. Patent No. 3,537 r 967. In order to achieve this beneficial synergistic effect the weigh~ ratio of thiosynergist to l isocyanurate stabilizers should be between about 1:1 and up to ! about 5:1. This ratio range is typical for most other antioxidant ~0 ¦ thiosynergist combinations, e.g. those shown and discussed by ¦IHirao in U.S. Patent No. 3,940j325.
It is an object of the present invention to provide l¦novèl compositions of matter of polymers of propylene which are ;Iresistant to discoloration and to degradation of physical proper-¦¦ties upon high energy radiation treatment.
It is a further object of this invention to provide ¦¦shaped articles of polymers of propylene which can be used for medical or food packaging purposes, which shaped articles have ~been subjected to a sterilizing dose of high energy radiation.
¦I THE INVENTION
¦ The above objects are unexpectedly accomplished by in-corporating into a propylene polymer (a) from about 200 to about 400 ppm of a phenolic antioxidant containing an isocyanurate group
- 3 -Il .
in its molecular structure, (b) a thiosynergist in an amount which ¦is at least 6 times the amount of the antioxidant of (a), and sub-jecting the resulting composition to a dose of high energy radia-tion.
Illustrative examples of phenolic antioxidants contain-ing an isocyanurate group in the molecular structure are those having the general formula:
~2 _ O~ (1) wherein Rl and R2 independently from each other are either hydro-gen, an alkyl group of from 1 to 5 carbon atoms, or a group repre-sented by the formula:
x Q OH (2) wherein R3, R4 and R5 independently from each other are either hydrogen or a lower alkyl group containing from 1 to 5 carbon atoms, and X is a hydrocarbon linking group.
Preferably, Rl and R2 are both groups represented by the ~formula (2) given above. R3 and R4 are preferably alkyl groups and most preferably tertiary alkyl groups such as t-butyl and t-amyl.
The linking group -X- can generally be any hydrocarbon group providin~ the necessary linkage between the isocyanurate group and the phenolic group.
For instance, X can be a group represented by the formu-la: .
I' R6 i l CH2 (3) , R7 Il ¦Iwherein R6 and R7 independently from each other can be either ¦¦hydrogen or an alkyl group having from 1 to 6 carbon atoms. Phen-i~olic antioxidant compounds containing such linking groups are known ,!in the art and can be prepared e.g. by the condensation reaction ¦io a phenol ~containing the R3 - R5 groups as defined above), an appropriate aldehyde and isocyanuric acid (con~taining the Rl and R2 groups defined above) with the formation of water as byproduct.
¦ Other suitable X groups include those represented by l,the formula:
- (CH2)a O C (CH2)b ~wherein a and b independently from each other are each at least 2 l¦and a + b ranges from 4 to 18.
il Compounds containing these linking groups are also well ilknown in the art. Generally, the compounds can be prepared by , first reacting a phenol, (as defined before), with an appropriate ester having the formula CH2 = CH (CHz)a 2 COOR8 wherein R8 j,is a lower alkyl group such as methyl, ethyl, propyl or butyl (the ¦¦base catalyzed Michael reaction).
', In a separate step an isocyanuric acid (as defined be-jfore) is reacted with a halogen-substituted alkanol or thiol of ¦¦the general formula Y (CH2)b Z wherein Y is a halogen and Z
~¦is either -OH or -SH. After removal of byproduct HY, e.g. HCl when `Ithe halogen is chlorine, the reaction products from the above de-l¦scribed two steps are reacted with each other forming the desired Icompound and the corresponding R8 alcohol or thiol as byproduct.
1! 5 _ i I .
Analogous procedures can obviously ]~e used in preparing many other phenolic antioxidant compounds having additional groups ~present in the linking group, for instance, by the use of other 'halogen substituted alkanols or thiols such as '¦ y (CH2)d - S ~ (CH2)e Rg o Rlo Y (CH2)d - ~ - C - ~ ~ (CH2)e Z (6) Y (CH2) d ~ C (CH2) e ¦wherein d and e each are an integer of at lea:,t 2 , d + e ranges from 4 to 6, and a + d + e ranges from 6 to 18, Rg and Rlo each are either hydrogen or a hydroxyl group.
Il The phenolic compounds preferably employed in this inven-lS !¦tion are those having the linking groups - X - defined by formula~
¦(3) and (4) above, e.g. tris (3,5-di-t-butyl-4-hydroxybenzyl) iso-jlcyanurate and 3,5-di-t-butyl-4-hydrocinnamic acid triester with il1,3,5-tris (2-hydroxyethyl)-S-triazine-2,4,6 (lH, 3H, 5H)-trione.
,¦These compounds are commercially available.
1l In addition to the above specified phenolic antioxidants , the propylene polymer composition also contains a thiosynergist in ¦ amounts at least 6 times the weight of the antioxidant and gener-~ally in concentrations ranging from about 1201) ppm to about 3500 ppm. The thiosynergist is a dialkyl ester of thiodipropionic acid wherein the alkyl radicals-contain from 4 to 22 carbon atoms. Par-ticularly suitable diesters are those having alkyl groups contain-ing 18 carbon atoms namely distearyl thiodipropiorate and 22 car-bon atoms namely dilauryl thiodipropionate.
~.2~77 . 1.
" ~ A metal stearate such as calcium stearate or zinc stear-ate, is advantageously also incorporated as a processing aid, ¦iusually in amounts ranging from about 300 to about 700 ppm.
l The polymers of propylene applicable for use in this in-¦ vention are homopolymers of propylene and random or block copoly-mers of propylene with other mono ~-olefins such as ethylene, butene-l and higher homologues containing up to 10 carbon atoms.
Blends of such propylene polymers with other polymers such as polyethylene are also included within the scope of this invention.
Generally the proportion of polymerized propylene in the total ¦resin phase of the composition should be at least 60~ by weight.
¦ The propylene polymer compositions can be pigmented, if ~so desired. No significant distortion of color is observed after lexposure to sterilizing doses of high energy radiation, e.g.
phthalocyanine blue pigmented articles of manufacture retain their brilliant colors without development of green tones.
In general, the radiation treatment can be applied to polymers of propylene useful particularly for medical purposes;
Ihowever, this should not be understood to be a limiting factor as ¦~the radiation treatment can be applied to the propylene polymers ,ifor any use for which such a treatment is required, such as for l meat packaging, preserving food in retort packages and other uses.
! The high energy radiation is conveniently provided by a ¦cobalt 60 source. Other radiation treatment, however, can be used ~5 1! such as high energy X-rays or high energy electrons ( ~ -radia-¦tion). In general, radiation dosages that can be applied range ilup to about 5 megarads. For sterilization purposes, it has been i¦found that an article of manufacture such as a syringe can be ¦¦effectively sterilized by applying 2 megarads under gamma radia-¦I tion.
The following examples illustrate the invention without limiting it.
7'7 i EXAMPL~S 1 - 3 il . .
A propylene homopolymer resin having a melt flow of ¦4-5 g/10 min. was melt blended with 300 ppm by weight of a commer-l cially available phenolic isocyanurate Good-rite~ 3125 (which is ¦ the 3,5-di-t-butyl-4-hydroxy-hydrocinnamic triester of 1,3,5-tris I (2-hydroxy ethyl)-S-triazine-2,4,6 (lH, 3H, 5l~ -trione), 2000 ppm of either dilaurylthiodipropionate (DLTDP) or distearylthiodipro-pionate (DSTDP) and 500 ppm of either calcium stearate or zinc stearate. Tensile bar specimens (2 L/2" x 1/2" x 60 mil) were prepared from each of these blends and were then subjected to gamma irradiation with doses of 0, 1, 3 and 5 megarads respectively em-ploying a cobalt 60 source. Subsequently the.specimens were tested ¦¦for brittleness using a 2 x 180 manual flex test, in which the grip tab of the test bar is first bent 180 to one side and then bent back to the other side at 180~. The test is passed if neither a complete break nor a fibrous hinge results from the two bendings.
The yellowness index (ASTM D- 1925) the tensile properties ¦¦(ASTM D- 1708) were also determined. The pertinent data are shown in Table 1 below ~/
I! "r~f ~'' ,"..-~-"' f r- ' . ... ............ ..... ......... . .... . ..
8 ~ ~ ~e ~1 ~.2~
!i .
!~ Ex. No. 1 2 _ 3 !
~ Additives - ppm ! Good-rite~ 3125 300 300 300 ¦I DSTDP 2000 - . -i Ca Stearate 500 - 500 . Zn Stearate - 500 500 ! Properties i¦ 2 x 180 flex 0 Mrad ~ Passed 1 Mrad ( ----- Passed ~ .
3 Mrad Ç -~ Passed 5 Mrad ~ - Passed - -- ---~
Yellowness Index 0 Mrad -0,3 ~0.4 -0.4 1 Mrad 3 Mrad - 1.8 2.0 l 5 Mrad 3.2 .5.0 5.1 1 Tensile Yield - psi 0 Mrad 5381 5685 5228 1 Mrad 5282 5436 5456 3 Mrad 5448 5137 5430 5 Mrad ~ 5290 5541 5230 ~5 ¦ Tensile ~ail - psi . 3 3851 4176 3961 Il 5 - 3680 3659 3680 ! % Elongation I 0 Mrad 248 240 267 1 Mrad 218 208 236 3 Mrad 215 106 198 ,¦ 5 Mrad 189 41 175 'i .
ii The above compositions compared favorably with polypro-',pylene compositions stabilized solely with either D1TDP or DSTDP
jat 1400 to 3500 ppm incorporation in that the very pale and accept l¦able color developments (3-5YI) after irradiation at sterilizing i¦doses of 5 megarads were about the same or at most slightly higher ',while the physical properties were considerably improved over the 'ilcomparison compositions, which were brittle and failed the manual .
flex test.
- g _ !l .
j Resort can be made to modifications and equivalents ,Ifalling within the scope of the appended claims.
l _. - ~
. . , . I
in its molecular structure, (b) a thiosynergist in an amount which ¦is at least 6 times the amount of the antioxidant of (a), and sub-jecting the resulting composition to a dose of high energy radia-tion.
Illustrative examples of phenolic antioxidants contain-ing an isocyanurate group in the molecular structure are those having the general formula:
~2 _ O~ (1) wherein Rl and R2 independently from each other are either hydro-gen, an alkyl group of from 1 to 5 carbon atoms, or a group repre-sented by the formula:
x Q OH (2) wherein R3, R4 and R5 independently from each other are either hydrogen or a lower alkyl group containing from 1 to 5 carbon atoms, and X is a hydrocarbon linking group.
Preferably, Rl and R2 are both groups represented by the ~formula (2) given above. R3 and R4 are preferably alkyl groups and most preferably tertiary alkyl groups such as t-butyl and t-amyl.
The linking group -X- can generally be any hydrocarbon group providin~ the necessary linkage between the isocyanurate group and the phenolic group.
For instance, X can be a group represented by the formu-la: .
I' R6 i l CH2 (3) , R7 Il ¦Iwherein R6 and R7 independently from each other can be either ¦¦hydrogen or an alkyl group having from 1 to 6 carbon atoms. Phen-i~olic antioxidant compounds containing such linking groups are known ,!in the art and can be prepared e.g. by the condensation reaction ¦io a phenol ~containing the R3 - R5 groups as defined above), an appropriate aldehyde and isocyanuric acid (con~taining the Rl and R2 groups defined above) with the formation of water as byproduct.
¦ Other suitable X groups include those represented by l,the formula:
- (CH2)a O C (CH2)b ~wherein a and b independently from each other are each at least 2 l¦and a + b ranges from 4 to 18.
il Compounds containing these linking groups are also well ilknown in the art. Generally, the compounds can be prepared by , first reacting a phenol, (as defined before), with an appropriate ester having the formula CH2 = CH (CHz)a 2 COOR8 wherein R8 j,is a lower alkyl group such as methyl, ethyl, propyl or butyl (the ¦¦base catalyzed Michael reaction).
', In a separate step an isocyanuric acid (as defined be-jfore) is reacted with a halogen-substituted alkanol or thiol of ¦¦the general formula Y (CH2)b Z wherein Y is a halogen and Z
~¦is either -OH or -SH. After removal of byproduct HY, e.g. HCl when `Ithe halogen is chlorine, the reaction products from the above de-l¦scribed two steps are reacted with each other forming the desired Icompound and the corresponding R8 alcohol or thiol as byproduct.
1! 5 _ i I .
Analogous procedures can obviously ]~e used in preparing many other phenolic antioxidant compounds having additional groups ~present in the linking group, for instance, by the use of other 'halogen substituted alkanols or thiols such as '¦ y (CH2)d - S ~ (CH2)e Rg o Rlo Y (CH2)d - ~ - C - ~ ~ (CH2)e Z (6) Y (CH2) d ~ C (CH2) e ¦wherein d and e each are an integer of at lea:,t 2 , d + e ranges from 4 to 6, and a + d + e ranges from 6 to 18, Rg and Rlo each are either hydrogen or a hydroxyl group.
Il The phenolic compounds preferably employed in this inven-lS !¦tion are those having the linking groups - X - defined by formula~
¦(3) and (4) above, e.g. tris (3,5-di-t-butyl-4-hydroxybenzyl) iso-jlcyanurate and 3,5-di-t-butyl-4-hydrocinnamic acid triester with il1,3,5-tris (2-hydroxyethyl)-S-triazine-2,4,6 (lH, 3H, 5H)-trione.
,¦These compounds are commercially available.
1l In addition to the above specified phenolic antioxidants , the propylene polymer composition also contains a thiosynergist in ¦ amounts at least 6 times the weight of the antioxidant and gener-~ally in concentrations ranging from about 1201) ppm to about 3500 ppm. The thiosynergist is a dialkyl ester of thiodipropionic acid wherein the alkyl radicals-contain from 4 to 22 carbon atoms. Par-ticularly suitable diesters are those having alkyl groups contain-ing 18 carbon atoms namely distearyl thiodipropiorate and 22 car-bon atoms namely dilauryl thiodipropionate.
~.2~77 . 1.
" ~ A metal stearate such as calcium stearate or zinc stear-ate, is advantageously also incorporated as a processing aid, ¦iusually in amounts ranging from about 300 to about 700 ppm.
l The polymers of propylene applicable for use in this in-¦ vention are homopolymers of propylene and random or block copoly-mers of propylene with other mono ~-olefins such as ethylene, butene-l and higher homologues containing up to 10 carbon atoms.
Blends of such propylene polymers with other polymers such as polyethylene are also included within the scope of this invention.
Generally the proportion of polymerized propylene in the total ¦resin phase of the composition should be at least 60~ by weight.
¦ The propylene polymer compositions can be pigmented, if ~so desired. No significant distortion of color is observed after lexposure to sterilizing doses of high energy radiation, e.g.
phthalocyanine blue pigmented articles of manufacture retain their brilliant colors without development of green tones.
In general, the radiation treatment can be applied to polymers of propylene useful particularly for medical purposes;
Ihowever, this should not be understood to be a limiting factor as ¦~the radiation treatment can be applied to the propylene polymers ,ifor any use for which such a treatment is required, such as for l meat packaging, preserving food in retort packages and other uses.
! The high energy radiation is conveniently provided by a ¦cobalt 60 source. Other radiation treatment, however, can be used ~5 1! such as high energy X-rays or high energy electrons ( ~ -radia-¦tion). In general, radiation dosages that can be applied range ilup to about 5 megarads. For sterilization purposes, it has been i¦found that an article of manufacture such as a syringe can be ¦¦effectively sterilized by applying 2 megarads under gamma radia-¦I tion.
The following examples illustrate the invention without limiting it.
7'7 i EXAMPL~S 1 - 3 il . .
A propylene homopolymer resin having a melt flow of ¦4-5 g/10 min. was melt blended with 300 ppm by weight of a commer-l cially available phenolic isocyanurate Good-rite~ 3125 (which is ¦ the 3,5-di-t-butyl-4-hydroxy-hydrocinnamic triester of 1,3,5-tris I (2-hydroxy ethyl)-S-triazine-2,4,6 (lH, 3H, 5l~ -trione), 2000 ppm of either dilaurylthiodipropionate (DLTDP) or distearylthiodipro-pionate (DSTDP) and 500 ppm of either calcium stearate or zinc stearate. Tensile bar specimens (2 L/2" x 1/2" x 60 mil) were prepared from each of these blends and were then subjected to gamma irradiation with doses of 0, 1, 3 and 5 megarads respectively em-ploying a cobalt 60 source. Subsequently the.specimens were tested ¦¦for brittleness using a 2 x 180 manual flex test, in which the grip tab of the test bar is first bent 180 to one side and then bent back to the other side at 180~. The test is passed if neither a complete break nor a fibrous hinge results from the two bendings.
The yellowness index (ASTM D- 1925) the tensile properties ¦¦(ASTM D- 1708) were also determined. The pertinent data are shown in Table 1 below ~/
I! "r~f ~'' ,"..-~-"' f r- ' . ... ............ ..... ......... . .... . ..
8 ~ ~ ~e ~1 ~.2~
!i .
!~ Ex. No. 1 2 _ 3 !
~ Additives - ppm ! Good-rite~ 3125 300 300 300 ¦I DSTDP 2000 - . -i Ca Stearate 500 - 500 . Zn Stearate - 500 500 ! Properties i¦ 2 x 180 flex 0 Mrad ~ Passed 1 Mrad ( ----- Passed ~ .
3 Mrad Ç -~ Passed 5 Mrad ~ - Passed - -- ---~
Yellowness Index 0 Mrad -0,3 ~0.4 -0.4 1 Mrad 3 Mrad - 1.8 2.0 l 5 Mrad 3.2 .5.0 5.1 1 Tensile Yield - psi 0 Mrad 5381 5685 5228 1 Mrad 5282 5436 5456 3 Mrad 5448 5137 5430 5 Mrad ~ 5290 5541 5230 ~5 ¦ Tensile ~ail - psi . 3 3851 4176 3961 Il 5 - 3680 3659 3680 ! % Elongation I 0 Mrad 248 240 267 1 Mrad 218 208 236 3 Mrad 215 106 198 ,¦ 5 Mrad 189 41 175 'i .
ii The above compositions compared favorably with polypro-',pylene compositions stabilized solely with either D1TDP or DSTDP
jat 1400 to 3500 ppm incorporation in that the very pale and accept l¦able color developments (3-5YI) after irradiation at sterilizing i¦doses of 5 megarads were about the same or at most slightly higher ',while the physical properties were considerably improved over the 'ilcomparison compositions, which were brittle and failed the manual .
flex test.
- g _ !l .
j Resort can be made to modifications and equivalents ,Ifalling within the scope of the appended claims.
l _. - ~
. . , . I
Claims (24)
1. A method for imparting improved strength and discoloration resistance to a stabilized, high energy radiation treated propylene polymer which comprises incorporating into said propylene polymer as a stabilizer from about 200 to about 400 ppm of a phenolic antioxidant containing an isocyanurate group in its molecular structure and a thiosynergist in an amount of at least 6 times the weight of said stabilizer prior to subjecting said propylene polymer to a sterilizing dose of high energy radiation.
2. The method of claim 1, in which the phenolic antioxidant has the formula wherein R1 and R2 independently from each other are either hydrogen, an alkyl group of 1 to 5 hydrocarbons or a group represented by the formula R3, R4 and R5 independently from each other are either hydro-gen or an alkyl group of from 1 to 5 carbon atoms, and X is a hydrocarbon linking group.
3. The method of claim 1, wherein the thiosynergist is a dialkyl ester of thiodipropionic acid and is present in amounts from about 1200 to about 3500 ppm.
4. The method of claim 1, wherein from about 300 to about 700 ppm of calcium stearate or zinc stearate is incorporated into the propylene polymer prior to subjecting said propylene polymer to the high energy radiation.
5. The method of claim 2, wherein R1 and R2 are both a group represented by the formula
6. The method of claim 2, wherein R3 and R4 are alkyl groups.
7. The method of claim 2, wherein R3 and R4 are tertiary alkyl groups.
8. The method of claim 2, wherein -X- is selected from the groups represented by the formulae (a) wherein R6 and R7 independently from each other is either hydrogen or an alkyl group having from 1 to 6 hydrocarbons, or (b) wherein a and b independently from each other are at least 2 and a + b ranges from 4 to 18.
9. The method of claim 2 wherein the phenolic antioxidant is selected from tris (3,5-di-t-butyl-4-hydroxybenzyl) isocyan-urate or 3,5-di-t-butyl-4-hydrocinnamic triester with 1,3,5-tris(2-hydroxy ethyl)-S-triazine-2,4,6 (1H, 3H, 5H)-trione.
10. The method of claim 1, wherein said high energy radiation is gamma radiation.
11. The method of claim 10, wherein the sterilizing dose is at least about 2 megarads and up to 5 megarads.
12. The method of claim 4, wherein the thiosynergist is either distearylthiodipropionate or dilaurylthiodipropionate.
13. A shaped article of manufacture of improved strength and dis-coloration resistance shaped from a propylene polymer having incorporated therein as a stabilizer from about 200 to about 400 ppm of a phenolic antioxidant containing an isocyanurate group in its molecular structure and a thiosynergist in an amount of at least 6 times the weight of said stabilizer, said shaped article having been subjected to a sterilizing dose of high energy radiation.
14. The article of claim 13, in which the phenolic antioxidant has the formula wherein R1 and R2 independently from each other are either hydrogen, an alkyl group of 1 to 5 hydrocarbons or a group represented by the formula R3, R4 and R5 independently from each other are either hydro-gen or an alkyl group of from 1 to 5 carbon atoms, and X is a hydrocarbon linking group.
15. The article of claim 13, wherein the thiosynergist is a di-alkyl ester of thiodipropionic acid and is present in amounts from about 1200 to about 3500 ppm.
16. The article of claim 13, wherein from about 300 to about 700 ppm of calcium stearate or zinc stearate is incorporated into the propylene polymer.
17. The article of claim 14, wherein R1 and R2 are both a group represented by the formula
18. The article of claim 14, wherein R3 and R4 are alkyl groups.
19. The article of claim 14, wherein R3 and R4 are tertiary alkyl groups.
20. The article of claim 14, wherein -X- is selected from the groups represented bv the formulae (a) wherein R6 and R7 independently from each other is elther hydrogen or an alkyl group having from 1 to 6 hydrocarbons, or (b) wherein a and b independently from each other are at least 2 and a + b ranges from 4 to 18.
21. The article of claim 14 wherein the phenolic antioxidant is selected from tris (3,5-di-t-butyl-4-hydroxybenzyl) isocyan-urate or 3,5-di-t-butyl-4-hydrocinnamic triester with 1,3,5-tris (2-hydroxy ethyl)-S-triazine-2,4,6 (lH, 3H, 5H)-trione.
22. The article of claim 13, wherein said high energry radiation is gamma radiation.
23. The article of claim 22, wherein the sterilizing dose is at least about 2 megarads ancd up to 5 megarads.
24. The article of claim 16, wherein the thiosynergist is either distearylthiodipropionate or dilaurylthiodipropionate.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1556179A | 1979-02-26 | 1979-02-26 | |
| US015,561 | 1979-02-26 | ||
| US8656079A | 1979-10-31 | 1979-10-31 | |
| US086,560 | 1979-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1124677A true CA1124677A (en) | 1982-06-01 |
Family
ID=26687552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA345,495A Expired CA1124677A (en) | 1979-02-26 | 1980-02-13 | Radiation treated propylene polymers |
Country Status (4)
| Country | Link |
|---|---|
| CA (1) | CA1124677A (en) |
| FR (1) | FR2449703A1 (en) |
| GB (1) | GB2043079B (en) |
| NO (1) | NO800408L (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1164127A (en) * | 1981-02-23 | 1984-03-20 | Borg-Warner Chemicals, Inc. | Radiation-resistant olefin polymer |
| US4507415A (en) * | 1982-03-27 | 1985-03-26 | Terumo Kabushiki Kaisha | Medical articles |
| JPS5911249A (en) * | 1982-07-09 | 1984-01-20 | 住友化学工業株式会社 | Polypropylene group resin film for evaporating aluminum |
| JPS62109840A (en) * | 1985-07-17 | 1987-05-21 | Tokuyama Soda Co Ltd | Polypropylene composition |
| US4797438A (en) * | 1987-05-11 | 1989-01-10 | The B. F. Goodrich Company | Stabilized gamma-irradiated polypropylene and sterilizable articles thereof |
| US4820755A (en) * | 1987-08-18 | 1989-04-11 | American Cyanamid Company | Radiation sterilizable composition and articles made therefrom |
| US5122593A (en) * | 1989-02-22 | 1992-06-16 | The B. F. Goodrich Company | Stabilized gamma-irradiatable polypropylene fibers and sterilizable articles thereof |
| US6363890B1 (en) * | 1998-03-06 | 2002-04-02 | Kenneth C. Beck | Package for animal bedding pads |
| CA3067853A1 (en) | 2017-06-29 | 2019-01-03 | Arkema Inc. | Polymer compositions stabilized with organopolysulfides |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB422454A (en) * | 1933-08-19 | 1935-01-11 | Egon Runte | Stop cock or valve for gas or liquid medium carrying pipes |
| BE757330A (en) * | 1969-10-10 | 1971-04-09 | Flume Stabilization Syst | METHOD AND APPARATUS FOR THE STABILIZATION OF A |
-
1980
- 1980-02-06 GB GB8003919A patent/GB2043079B/en not_active Expired
- 1980-02-13 CA CA345,495A patent/CA1124677A/en not_active Expired
- 1980-02-14 NO NO800408A patent/NO800408L/en unknown
- 1980-02-25 FR FR8004089A patent/FR2449703A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| FR2449703A1 (en) | 1980-09-19 |
| GB2043079B (en) | 1982-12-08 |
| NO800408L (en) | 1980-08-27 |
| GB2043079A (en) | 1980-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4431497A (en) | Radiation-stable polyolefin compositions | |
| US4888369A (en) | Polypropylene composition resistant to high energy radiation, and radiation sterilized articles therefrom | |
| US4666959A (en) | Radiation sterilizable propylene polymer compositions and articles manufactured therefrom | |
| US4460445A (en) | Radiation-stable polyolefin compositions containing benzaldehyde acetals | |
| US4820755A (en) | Radiation sterilizable composition and articles made therefrom | |
| CA1124677A (en) | Radiation treated propylene polymers | |
| US3069369A (en) | Color stabilized polyethylene compounds | |
| EP1129133A1 (en) | Thermoplastic resins stabilized by blends of sterically hindered phenols, secondary amines, and thioethers | |
| US4302383A (en) | Stabilized olefin polymers | |
| US4412897A (en) | Process for rendering polymers resistant to ionizing radiation, and compositions obtained thereby | |
| JPS62109840A (en) | Polypropylene composition | |
| EP0538509B1 (en) | Highly antioxidant resin composition | |
| US4515666A (en) | Radiation-stable polyolefin compositions containing aromatic ketone compounds | |
| US4657949A (en) | Gamma radiation resistant carbonate polymer compositions with sorbates | |
| EP0227948B1 (en) | Improved phosphite stabilizer compositions | |
| USRE26158E (en) | Poly-a-olefin compositions containing di- alkyl-j,j -thiodipropionates and a ni- trogen containing compound | |
| EP0303894A2 (en) | Radiation sterilizable composition and articles made therefrom | |
| US2335089A (en) | Method of preserving rubber | |
| Hoffman III et al. | Radiation treated propylene polymers | |
| CA1184331A (en) | Light-stable polyolefins | |
| US3694374A (en) | Antioxidant mixture of an amineborate and a ketonephenol or aldehydephenol | |
| JPH0513181B2 (en) | ||
| US3450671A (en) | Poly-alpha-olefin compositions containing dialkyl - 3,3' - thiodipropionates and polyphenols | |
| EP0136381B1 (en) | Polyolefin compositions | |
| US3091598A (en) | Poly-alpha-olefins containing thiobisphenols and butylated hydroxy toluene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |